Browsing Tag
Agenus Inc.
2 posts
Agenus–Zydus $141m immuno-oncology deal sets stage for global BOT/BAL expansion and U.S. biologics manufacturing pivot
Agenus partners with Zydus in a $141M deal to expand BOT/BAL globally and transfer U.S. biologics assets—find out what it means for cancer immunotherapy.
Hope for bladder cancer patients? UroGen’s UGN-301 shows strong safety and clinical activity in early trial
Find out how UroGen Pharma’s UGN-301 is offering new hope for bladder cancer patients with promising Phase 1 trial results. Read the latest developments here!